Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Awareness, Care, and Treatment In Obesity Management of Patients With Hemophilia (ACTION) to Inform Hemophilia Obesity Patient Empowerment (HOPE)

NCT03430154 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT03430154
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03430154 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Awareness, Care, and Treatment In Obesity Management of Patients With Hemophilia (ACTION) to Inform Hemophilia Obesity Patient Empowerment (HOPE)
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Completed
Start date
December 1, 2017
Completion date
April 29, 2018
Enrollment
317 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

haemophilia a, haemophilia b, obesity